Form 4: GE HealthCare Technologies Inc. Executive Adam Y. Holton Reports Stock and Option Awards
SEC Form 4 Filing
Chief People Officer Adam Y. Holton reports the acquisition of restricted stock units and an employee stock option in GE HealthCare Technologies Inc.
Summary
- Adam Y. Holton, Chief People Officer of GE HealthCare Technologies Inc., filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2025, Holton acquired 4,337 restricted stock units (RSUs) and an employee stock option for 12,404 shares.
- The RSUs will vest in three tranches: 33% on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028.
- The employee stock option also vests in three tranches on the same dates and has an exercise price of $86.45.
- Following these transactions, Holton directly owns 17,232 shares of GE HealthCare common stock and an option to purchase 12,404 shares.
- The filing was signed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact on March 5, 2025.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, aligning management interests with shareholders.
Positives
- The grant of RSUs and stock options to a key executive aligns their interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the executive.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Executive compensation packages including stock options and restricted stock units are common practice in publicly traded companies to incentivize performance and align executive interests with shareholder value.
- Vesting schedules are typically structured over a multi-year period to encourage long-term commitment.
Stakeholder Impact
- Shareholders may view the granting of stock options and RSUs as a positive sign, aligning executive interests with company performance.
- Employees may see this as a positive sign of investment in leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: acquisition of restricted stock units and employee stock option. |
| 03/05/2025 | Date of filing: Form 4 filing date. |
| 09/03/2026 | First vesting date for 33% of the restricted stock units and employee stock option. |
| 09/03/2027 | Second vesting date for 33% of the restricted stock units and employee stock option. |
| 09/03/2028 | Final vesting date for 34% of the restricted stock units and employee stock option. |
| 03/03/2035 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.